Valuation: Psychemedics Corporation

Market Cap 9.79M 8.78M 8.12M 7.36M 13.74M 933M 13.91M 97.11M 38.68M 488M 36.74M 35.97M 1.55B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.56M 7.91M 7.17M 13.39M 909M 13.55M 94.62M 37.69M 475M 35.8M 35.04M 1.51B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+9.09%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+14.29%-2.04% 15.26M
-1.10%-3.63%+9.56%+32.42% 117B
+2.10%+0.11%-1.41%+105.92% 97.42B
+4.36%+4.23%+127.29%+1,047.47% 59.22B
-0.21%+3.23%-5.94%+90.00% 29.03B
+9.39%+12.06%+39.70%+83.07% 26.86B
+1.16%+2.77%+37.73%+89.74% 26.69B
+2.09%-0.27%+31.17%+404.06% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +1.88%-0.14%+22.93%+188.09% 41.44B
Weighted average by Cap. +1.65%-1.33%+25.63%+222.96%

Financials

2023 2024
Net sales 22.1M 19.83M 18.33M 16.6M 31.02M 2.1B 31.39M 219M 87.29M 1.1B 82.92M 81.17M 3.5B 19.68M 17.66M 16.33M 14.79M 27.63M 1.87B 27.96M 195M 77.76M 981M 73.87M 72.31M 3.11B
Net income -4.15M -3.73M -3.45M -3.12M -5.83M -396M -5.9M -41.2M -16.41M -207M -15.59M -15.26M -657M -1.86M -1.67M -1.54M -1.4M -2.61M -177M -2.64M -18.46M -7.35M -92.75M -6.98M -6.84M -294M
Net Debt 334K 300K 277K 251K 469K 31.81M 474K 3.31M 1.32M 16.65M 1.25M 1.23M 52.84M -251K -225K -208K -189K -352K -23.91M -357K -2.49M -992K -12.51M -942K -922K -39.71M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock